FDA Inspection
American National Red CrossAmerican National Red Cross – FDA Inspection, Oct 24, 2023
Record Details
This FDA Inspection record concerns American National Red Cross, with an inspection on October 24, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 3785b86c-2584-4749-a5a1-33244af4b1d6
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1221160
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 640.25(a)Storage temps./agitation
- 21 CFR 640.25(a)Storage temps./agitation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of American National Red Cross
2| Date | Classification | Office | Project area |
|---|---|---|---|
| February 11, 2026 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 9, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
Other documents for American National Red Cross
- FDA Inspection 1291202 - 2026-02-11
- FDA Inspection 1177541 - 2022-08-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.